Diabetes

The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.

USPSTF Issues First Recommendation Statement on Type 2 Diabetes Screening in Children and Adolescents

September 13, 2022

Released on September 13, the US Preventive Services Task Force concluded there was a lack of sufficient evidence related to the benefits and harms of screening in their first-ever recommendation statement on screening for type 2 diabetes and prediabetes in children with no known history or symptoms of either disease.

In Gestational Diabetes, Tighter Glycemic Targets Could Influence Outcomes for Mother and Child

September 11, 2022

Results of the TARGET trial provide insight into the effects of tight glycemic targets versus less tight targets on maternal and perinatal outcomes among women with gestational diabetes.

Open-Source AID Systems Can Improve Glycemic Control in Both Children and Adults with Type 1 Diabetes

September 09, 2022

Results of the CREATE trial published in NEJM suggest the use of open-source automated insulin delivery systems was associated with improved time in target glucose range compared with sensor-augmented pump therapy in children and adults with type 1 diabetes.

FDA Updates Finerenone Label to Reflect Cardiovascular Outcomes Data

September 08, 2022

On September 1, Bayer announced the US FDA had approved a label update for finerenone (Kerendia), which received initial approval in July 2021 for chronic kidney disease associated with type 2 diabetes, to include cardiovascular outcomes data from the FIGARO-DKD trial.

Despite Improved Risk Profiles, Women with Type 1 Diabetes Face Increased CVD Risk

September 08, 2022

An analysis of patient data from the DCCT and EDIC studies details differences in the cardiometabolic risk factor profiles and management approaches for women and men with type 1 diabetes.

T2D Diagnosis Before 40 Linked to More Than 5-fold Increase in Risk of All-Cause and Cardiovascular Mortality

September 07, 2022

A study presented at EASD 22 comparing 600k patients with type 2 diabetes against 1.2 million controls suggests a diagnosis of T2D prior to turning 40 was associated with a more than 5-fold increase in risk of mortality, heart failure hospitalization, and coronary heart disease.

High HbA1c Linked to Increased Risk of Trigger Finger in Both Type 1 & Type 2 Diabetes

September 06, 2022

An analysis of national register data from Sweden suggests elevated HbA1c levels were linked to an increase in the likelihood of developing stenosing tenosynovitis, more commonly known as trigger finger, among people with either type 1 or type 2 diabetes.

Understanding Insulin Sensitivity, Adiposity, and Atherosclerosis, with Gregory Weiss, MD

September 05, 2022

In his most recent column, Dr. Gregory Weiss provides perspective on recent data elucidating the links between insulin sensitivity, central adiposity, and atherosclerosis.

Risk of Kidney Decline in T1D Heightened for People of African Caribbean Ethnicity

September 03, 2022

An analysis of data from more than 5500 people with type 1 diabetes and preserved kidney function at baseline suggests patients of African Caribbean ethnicity had a more than 50% greater risk of kidney function decline of 50% or greater than patients of other ethnic backgrounds.

In Type 1 Diabetes, Glycemic Control in Adolescence Can Stave Off Neurological Damage

September 01, 2022

An analysis assessing the benefits of hybrid closed loop systems in patients with T1D has returned results suggesting improved glycemic control could help preserve neurological function among adolescents with type 1 diabetes.